These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16702314)

  • 1. Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells.
    Harris GK; Qian Y; Leonard SS; Sbarra DC; Shi X
    J Nutr; 2006 Jun; 136(6):1517-21. PubMed ID: 16702314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection by chrysin, apigenin, and luteolin against oxidative stress is mediated by the Nrf2-dependent up-regulation of heme oxygenase 1 and glutamate cysteine ligase in rat primary hepatocytes.
    Huang CS; Lii CK; Lin AH; Yeh YW; Yao HT; Li CC; Wang TS; Chen HW
    Arch Toxicol; 2013 Jan; 87(1):167-78. PubMed ID: 22864849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of flavonoids on prostaglandin E2 production and on COX-2 and mPGES-1 expressions in activated macrophages.
    Hämäläinen M; Nieminen R; Asmawi MZ; Vuorela P; Vapaatalo H; Moilanen E
    Planta Med; 2011 Sep; 77(13):1504-11. PubMed ID: 21341175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteolin and luteolin-7-O-glucoside from dandelion flower suppress iNOS and COX-2 in RAW264.7 cells.
    Hu C; Kitts DD
    Mol Cell Biochem; 2004 Oct; 265(1-2):107-13. PubMed ID: 15543940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages.
    Hougee S; Sanders A; Faber J; Graus YM; van den Berg WB; Garssen J; Smit HF; Hoijer MA
    Biochem Pharmacol; 2005 Jan; 69(2):241-8. PubMed ID: 15627476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Anti-Inflammatory Activities by the Combination of Luteolin and Tangeretin.
    Funaro A; Wu X; Song M; Zheng J; Guo S; Rakariyatham K; Rodriguez-Estrada MT; Xiao H
    J Food Sci; 2016 May; 81(5):H1320-7. PubMed ID: 27095513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory effect of Adelia ricinella L. aerial parts.
    Berenguer-Rivas CA; Escalona-Arranz JC; Llauradó-Maury G; Van der Auwera A; Piazza S; Méndez-Rodríguez D; Foubert K; Cos P; Pieters L
    J Pharm Pharmacol; 2021 Mar; 73(4):553-559. PubMed ID: 33793832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The O-methylation of chrysin markedly improves its intestinal anti-inflammatory properties: Structure-activity relationships of flavones.
    During A; Larondelle Y
    Biochem Pharmacol; 2013 Dec; 86(12):1739-46. PubMed ID: 24134915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of luteolin on COX-2 and mPGES-1 expression in LPS-induced RAW264.7 cells].
    Wang XG; Chen GY; Chen MP
    Zhong Yao Cai; 2007 Oct; 30(10):1263-6. PubMed ID: 18300499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteolin suppresses inflammation-associated gene expression by blocking NF-kappaB and AP-1 activation pathway in mouse alveolar macrophages.
    Chen CY; Peng WH; Tsai KD; Hsu SL
    Life Sci; 2007 Nov; 81(23-24):1602-14. PubMed ID: 17977562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Inflammatory and Anti-Oxidative Effects of luteolin-7-
    Cho YC; Park J; Cho S
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32187984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages.
    Chen YC; Shen SC; Lee WR; Hou WC; Yang LL; Lee TJ
    J Cell Biochem; 2001; 82(4):537-48. PubMed ID: 11500931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-γ activation.
    El-Bassossy HM; Abo-Warda SM; Fahmy A
    Am J Chin Med; 2014; 42(5):1153-67. PubMed ID: 25169908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of C-glycosylation of luteolin on its antioxidant, anti-Alzheimer's disease, anti-diabetic, and anti-inflammatory activities.
    Choi JS; Islam MN; Ali MY; Kim YM; Park HJ; Sohn HS; Jung HA
    Arch Pharm Res; 2014 Oct; 37(10):1354-63. PubMed ID: 24988985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteolin and apigenin derived glycosides from Alphonsea elliptica abrogate LPS-induced inflammatory responses in human plasma.
    Attiq A; Jalil J; Husain K; Mohamad HF; Ahmad A
    J Ethnopharmacol; 2021 Jul; 275():114120. PubMed ID: 33857595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lipopolysaccharide-induced prostaglandin E2 production and inflammation by the Na+/H+ exchanger inhibitors.
    Kamachi F; Ban HS; Hirasawa N; Ohuchi K
    J Pharmacol Exp Ther; 2007 Apr; 321(1):345-52. PubMed ID: 17237260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UVB-induced DNA damage, generation of reactive oxygen species, and inflammation are effectively attenuated by the flavonoid luteolin in vitro and in vivo.
    Wölfle U; Esser PR; Simon-Haarhaus B; Martin SF; Lademann J; Schempp CM
    Free Radic Biol Med; 2011 May; 50(9):1081-93. PubMed ID: 21281711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and inhibitory activity against COX-2 catalyzed prostaglandin production of chrysin derivatives.
    Dao TT; Chi YS; Kim J; Kim HP; Kim S; Park H
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1165-7. PubMed ID: 14980657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and vascular effects of cyclooxygenase-2 in brain.
    Brian JE; Moore SA; Faraci FM
    Stroke; 1998 Dec; 29(12):2600-6. PubMed ID: 9836773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eupafolin inhibits PGE2 production and COX2 expression in LPS-stimulated human dermal fibroblasts by blocking JNK/AP-1 and Nox2/p47(phox) pathway.
    Tsai MH; Lin ZC; Liang CJ; Yen FL; Chiang YC; Lee CW
    Toxicol Appl Pharmacol; 2014 Sep; 279(2):240-51. PubMed ID: 24967690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.